Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ono

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ono's Japan sales performance.

Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

According to a statement issued by the NIH, the first trial participant is an American who was repatriated from the Diamond Princess cruise ship that docked in Yokohama, Japan.

Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA

Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA Last year, sales of Herceptin were flat overall at around $7bn, but fell 16% in Europe and Japan as biosimilars started to gather momentum.

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS scores first oesophageal cancer nod for Opdivo in Japan Approval in Japan comes before US okay. Bristol-Myers Squibb has won its first approval for Opdivo in oesophageal cancer, with an approval in Japan coming before a nod in the ... US. . Japan’s Ministry of Health, Labor and Welfare (MHLW) approved

Incyte’s JAK inhibitor cream clears second eczema trial

Incyte’s JAK inhibitor cream clears second eczema trial Incyte has said it intends to market ruxolitinib cream itself in the US if approved, but may seek partnerships in other territories such as Europe and Japan.

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy The drug has also been approved for the cardiomyopathy indication in Japan, Brazil and Canada.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...
BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...

Infographics